← Back to Search

Physical Performance Assessment for Safe Return to Sport (CASE Trial)

N/A
Recruiting
Research Sponsored by Baylor Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1.5 hours
Awards & highlights
No Placebo-Only Group

Summary

This trial assesses an athlete's physical performance in response to dynamic exertion, in order to identify system impairments that may keep them from safely returning to their sport.

Who is the study for?
This trial is for athletes aged 10-22 who've had a concussion but are symptom-free at rest and cleared to play within the last 30 days. They must have played organized sports in the past year. It's not for those with severe brain injuries, cardiopulmonary conditions, certain mental health diagnoses, more than three concussions, diabetes, uncontrolled asthma, pregnancy or current COVID-19 symptoms.
What is being tested?
The CASE test measures an athlete's physical response during sport-specific activities to help decide if they're ready to return to sports after a concussion. It looks at physiological and symptomatic responses across various body positions typical of different sports like soccer and basketball.
What are the potential side effects?
Since CASE is an exercise-based assessment rather than a drug treatment, there aren't traditional side effects. However, it may provoke symptoms in recovering athletes which can inform healthcare professionals about their readiness to resume sporting activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1.5 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1.5 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Blood pressure (mmHg)
Heart rate (bpm)
Heart rate reserve (peak-rest), beats/min-1
+4 more
Secondary study objectives
Modified Post-Concussion Symptom Scale (PCSS) (0-6)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: CASEExperimental Treatment1 Intervention
In this prospective study the investigators aim to quantify participants' responses to physical activity. Participants will be asked to engage in physical activity, to identify any provocation of symptoms in adolescents ranging from ages 10 to 22 years. Responses to physical activity will be measured through physiologic markers (e.g., blood pressure, heart rate, oxygen saturation, rate of perceived exertion, dyspnea). Additionally, participants will be monitored for any changes in symptoms that occur during or after physical activity as measured by the modified PCSS symptom inventory.

Find a Location

Who is running the clinical trial?

Baylor Research InstituteLead Sponsor
206 Previous Clinical Trials
203,300 Total Patients Enrolled
Sports AcademyUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled

Media Library

CASE Clinical Trial Eligibility Overview. Trial Name: NCT05013307 — N/A
Return to Sport Research Study Groups: CASE
Return to Sport Clinical Trial 2023: CASE Highlights & Side Effects. Trial Name: NCT05013307 — N/A
CASE 2023 Treatment Timeline for Medical Study. Trial Name: NCT05013307 — N/A
~3 spots leftby Dec 2024